Owens & Minor Executives to Participate in Major Investor Conferences

Owens & Minor Inc. executives will participate in two investor conferences on December 2, 2025. They will engage in a fireside chat and one-on-one meetings at the Citi 2025 Global Healthcare Conference in Miami, and host one-on-one meetings at the Bank of America Leveraged Finance Conference in Boca Raton. A live webcast and replay of the Citi conference will be available on the Owens & Minor investor relations website.

Owens & Minor shares are trading lower after UBS downgraded the stock from Buy to Neutral and cut its price target from $7 to $4.

Owens & Minor (OMI): Valuation Outlook Following Strategic Shift to Patient Direct and Optum Health Partnership

Owens & Minor (OMI) is undergoing a strategic shift, focusing on its Patient Direct business after divesting its Products & Healthcare Services segment. A new partnership with Optum Health marks a significant move towards home-based care. Despite this, OMI's stock has plummeted 69% this year, raising concerns about its turnaround strategy amid ongoing losses. Analysts suggest a fair value of $6.12, indicating the stock is undervalued at its current price of $3.97. However, high debt and potential stagnation in revenue pose risks to future earnings.

Owens & Minor Faces Financial Risks with P&HS Segment Asset Sale

Owens & Minor's planned asset sale in the P&HS segment poses significant financial risks, including potential liabilities from divested businesses and obligations to indemnify buyers. These risks could negatively impact the company's financial health, cash flows, and operational results. The divestiture may also dilute future earnings, leading to possible write-offs of goodwill and intangible assets. The average stock price target for OMI is $6.28, indicating a 58.19% upside potential.

Owens & Minor (NYSE:OMI) Posts Earnings Results, Beats Expectations By $0.02 EPS

Owens & Minor (NYSE:OMI) reported quarterly earnings of $0.25 EPS, exceeding expectations of $0.23 by $0.02. The company experienced a 1.5% revenue increase year-over-year but had a negative net margin of 13.78%. Owens & Minor updated its FY 2025 EPS guidance to 1.020-1.070. The stock traded down to $4.97, with a market cap of $383.73 million. Analysts have mixed ratings, with a consensus rating of "Hold" and an average target price of $7.63. Insider transactions and institutional investments have also been noted.